Le Lézard
Classified in: Science and technology
Subject: PLW

Natcore Technology Receives U.S. Patent For Laser-Transferred IBC Solar Cells


ROCHESTER, N.Y., Nov. 30, 2017 /CNW/ -- The U.S. Patent Office has awarded patent no. 9,570,638 B2 to Natcore Technology Inc. (TSX-V: NXT; OTCQB: NTCXF) for "Laser-Transferred IBC (Interdigitated Back Contact) Solar Cells."

The patent abstract reads as follows:

A laser processing system can he utilized to produce high-performance interdigitated back contac1 (IBC) solar cells. The laser processing system can be utilized to ablate, transfer material, and/or laser-dope or laser fire contacts. Laser ablation can he utilized to remove and pattern openings in a passivated or emitter layer. Laser transferring may then he utilized to transfer dopant and/or contact materials to the patterned openings, thereby forming an interdigitated finger pattern. The laser processing system may also be utilized to plate a conductive material on top of the transferred dopant or contact materials.

According to Dr. David Levy, Natcore's Director of Research & Technology, "This patent was our first relating to low-cost back contact cells. Additional ones are in progress.

"The intellectual property covers a back contact cell with doping done by by a laser transfer process. In that process, the dopant is located on an expendable sheet and then transferred by the energy of the laser to the actual substrate. This permits a laser to accurately pattern the n and p regions of a back-contact solar cell."

Chuck Provini, Natcore's president and CEO, says, "This invention was an important step in the progression to where we are today. It is the formative work that has led to our multilayer foil structure."

Natcore has now received 32 patents. The company has an additional 33 patents pending.

Statements in this press release other than purely historical factual information, including statements relating to revenues or profits, or Natcore's future plans and objectives, or expected sales, cash flows, and capital expenditures constitute forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in Natcore's business, including risks inherent in the technology history. There can be no assurance that such forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on such statements. Except in accordance with applicable securities laws, Natcore expressly disclaims any obligation to update any forward-looking statements or forward-looking statements that are incorporated by reference herein.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact:
Chuck Provini
(585) 286-9180
[email protected]

SOURCE Natcore Technology


These press releases may also interest you

at 12:45
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:39
In an effort to provide the best service possible, enterprise developer Interfuse, has added several important improvements to its Knowledge Base application. Within this update, new pages accessible in the Knowledge Base include Recently Added,...

at 12:16
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:05
Kinaxis® Inc. , a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadranttm for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis...

at 12:05
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...

at 12:00
Today, Immutable Games, a global leader in web3 game development and publishing, announced the hiring of Priya Keshyap as Executive Producer for Guild of Guardians, the epic fantasy RPG which comes to mobile on May 15. Keshyap draws on more than a...



News published on and distributed by: